Chandrasekar C R, Mohammed R, Rafalla A A, Grimer R J
Musculoskeletal Oncology Unit, Royal Orthopaedic Hospital, Birmingham B31 2AP, UK.
Foot (Edinb). 2009 Mar;19(1):58-61. doi: 10.1016/j.foot.2008.09.004. Epub 2009 Jan 30.
Adamantinoma is rare, representing less than 1% of all primary malignant bone tumours. It is a slow growing low grade malignant tumour which is often clinically, radiologically and histologically mistaken for many other tumours like Ewing's sarcoma, synovial sarcoma, fibrosarcoma, metastatic carcinoma, fibrous cortical defect and osteofibrous dysplasia. Adamantinoma commonly occurs in the tibia. It is also known to occur in the fibula, femur, humerus, radius and ulna. Adamantinoma of the foot is extremely rare. There are few reported cases of metatarsal and cuneiform bone involvement. To our knowledge adamantinoma of the calcaneum has not been previously reported in the literature. We report the case of a male patient, aged 33 years, who was treated for adamantinoma of the calcaneum and followed for 16 years highlighting the difficulty in diagnosis and management of this rare tumor occurring at a rare site.
造釉细胞瘤很罕见,占所有原发性恶性骨肿瘤的比例不到1%。它是一种生长缓慢的低级别恶性肿瘤,在临床、放射学和组织学上常被误诊为许多其他肿瘤,如尤因肉瘤、滑膜肉瘤、纤维肉瘤、转移性癌、纤维皮质缺损和骨纤维发育不良。造釉细胞瘤常见于胫骨,也可见于腓骨、股骨、肱骨、桡骨和尺骨。足部造釉细胞瘤极为罕见。跖骨和楔骨受累的报道病例很少。据我们所知,跟骨造釉细胞瘤此前在文献中尚未有报道。我们报告一例33岁男性患者,其因跟骨造釉细胞瘤接受治疗并随访16年,突出了这种发生在罕见部位的罕见肿瘤在诊断和治疗上的困难。